Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030059815> ?p ?o ?g. }
- W2030059815 endingPage "120" @default.
- W2030059815 startingPage "99" @default.
- W2030059815 abstract "Renal transplantation is associated with several abnormalities of function and structure of the musculoskeletal system. Some of these skeletal problems result from incomplete resolution of abnormalities of bone and mineral metabolism present at the time of transplantation. In this regard, persistent hyperparathyroidism, diabetes mellitus type 1, and accumulation of β2-microglobulin may lead to residual skeletal effects despite excellent function of the allograft. Persistent hyperparathyroidism may accelerate bone loss and increase the risk for osteonecrosis, as well as cause hypercalcemia and hypophosphatemia; some patients with severe hyperparathyroidism require parathyroid surgery. Osteonecrosis is the most debilitating skeletal complication after transplantation and frequently requires surgical therapy. Although osteomalacia associated with aluminum overload generally resolves after transplantation, bone complications due to dialysis amyloidosis and diabetes mellitus type 1 often fail to improve. Alternatively, skeletal abnormalities can be acquired after transplantation. Most of the new derangements of bone and mineral metabolism are due to the immunosuppressive medications. Toxic effects of glucocorticoids on bone contribute to the pathogenesis of osteonecrosis, increase the risk for fractures by decreasing cancellous bone mass and synthesis of bone matrix, and dampen the linear growth response in pediatric recipients. Whether cyclosporine independently causes appreciable toxic effects on bone metabolism is not yet clear, but use of this drug increases the prevalence of gout and dental problems. Osteonecrosis, osteopenia, and short stature remain important skeletal complications in recipients of renal allografts. Therapeutic efforts should be directed toward alleviating pretransplant bone disease and attenuating bone loss after transplantation. Renal transplantation is associated with several abnormalities of function and structure of the musculoskeletal system. Some of these skeletal problems result from incomplete resolution of abnormalities of bone and mineral metabolism present at the time of transplantation. In this regard, persistent hyperparathyroidism, diabetes mellitus type 1, and accumulation of β2-microglobulin may lead to residual skeletal effects despite excellent function of the allograft. Persistent hyperparathyroidism may accelerate bone loss and increase the risk for osteonecrosis, as well as cause hypercalcemia and hypophosphatemia; some patients with severe hyperparathyroidism require parathyroid surgery. Osteonecrosis is the most debilitating skeletal complication after transplantation and frequently requires surgical therapy. Although osteomalacia associated with aluminum overload generally resolves after transplantation, bone complications due to dialysis amyloidosis and diabetes mellitus type 1 often fail to improve. Alternatively, skeletal abnormalities can be acquired after transplantation. Most of the new derangements of bone and mineral metabolism are due to the immunosuppressive medications. Toxic effects of glucocorticoids on bone contribute to the pathogenesis of osteonecrosis, increase the risk for fractures by decreasing cancellous bone mass and synthesis of bone matrix, and dampen the linear growth response in pediatric recipients. Whether cyclosporine independently causes appreciable toxic effects on bone metabolism is not yet clear, but use of this drug increases the prevalence of gout and dental problems. Osteonecrosis, osteopenia, and short stature remain important skeletal complications in recipients of renal allografts. Therapeutic efforts should be directed toward alleviating pretransplant bone disease and attenuating bone loss after transplantation." @default.
- W2030059815 created "2016-06-24" @default.
- W2030059815 creator A5025333819 @default.
- W2030059815 creator A5028902678 @default.
- W2030059815 creator A5090409853 @default.
- W2030059815 date "1992-02-01" @default.
- W2030059815 modified "2023-10-14" @default.
- W2030059815 title "Musculoskeletal Complications After Renal Transplantation: Pathogenesis and Treatment" @default.
- W2030059815 cites W1495876529 @default.
- W2030059815 cites W1515182093 @default.
- W2030059815 cites W1779014472 @default.
- W2030059815 cites W1962920716 @default.
- W2030059815 cites W1965534812 @default.
- W2030059815 cites W1965604857 @default.
- W2030059815 cites W1967420478 @default.
- W2030059815 cites W1969362407 @default.
- W2030059815 cites W1969630572 @default.
- W2030059815 cites W1972488771 @default.
- W2030059815 cites W1973144860 @default.
- W2030059815 cites W1974953723 @default.
- W2030059815 cites W1976049374 @default.
- W2030059815 cites W1977824869 @default.
- W2030059815 cites W1978083065 @default.
- W2030059815 cites W1979050172 @default.
- W2030059815 cites W1979673430 @default.
- W2030059815 cites W1981559031 @default.
- W2030059815 cites W1982981070 @default.
- W2030059815 cites W1985807246 @default.
- W2030059815 cites W1986188782 @default.
- W2030059815 cites W1988038970 @default.
- W2030059815 cites W1993098386 @default.
- W2030059815 cites W1993850923 @default.
- W2030059815 cites W1993933464 @default.
- W2030059815 cites W1994467281 @default.
- W2030059815 cites W1998280405 @default.
- W2030059815 cites W2004631439 @default.
- W2030059815 cites W2006122998 @default.
- W2030059815 cites W2013072454 @default.
- W2030059815 cites W2014348329 @default.
- W2030059815 cites W2016554055 @default.
- W2030059815 cites W2016618557 @default.
- W2030059815 cites W2017549231 @default.
- W2030059815 cites W2018461052 @default.
- W2030059815 cites W2027698318 @default.
- W2030059815 cites W2028350702 @default.
- W2030059815 cites W2031170440 @default.
- W2030059815 cites W2031400454 @default.
- W2030059815 cites W2031790144 @default.
- W2030059815 cites W2034057547 @default.
- W2030059815 cites W2037660591 @default.
- W2030059815 cites W2038615990 @default.
- W2030059815 cites W2038836468 @default.
- W2030059815 cites W2040216771 @default.
- W2030059815 cites W2044094823 @default.
- W2030059815 cites W2048662407 @default.
- W2030059815 cites W2049008427 @default.
- W2030059815 cites W2049136271 @default.
- W2030059815 cites W2049320489 @default.
- W2030059815 cites W2051876718 @default.
- W2030059815 cites W2053524560 @default.
- W2030059815 cites W2054898497 @default.
- W2030059815 cites W2059839825 @default.
- W2030059815 cites W2061201190 @default.
- W2030059815 cites W2063421142 @default.
- W2030059815 cites W2063505798 @default.
- W2030059815 cites W2067464494 @default.
- W2030059815 cites W2070100542 @default.
- W2030059815 cites W2070843105 @default.
- W2030059815 cites W2072836764 @default.
- W2030059815 cites W2073157588 @default.
- W2030059815 cites W2073440305 @default.
- W2030059815 cites W2073840991 @default.
- W2030059815 cites W2076918876 @default.
- W2030059815 cites W2077404802 @default.
- W2030059815 cites W2077934148 @default.
- W2030059815 cites W2078641399 @default.
- W2030059815 cites W2082043748 @default.
- W2030059815 cites W2084022710 @default.
- W2030059815 cites W2085594293 @default.
- W2030059815 cites W2088794180 @default.
- W2030059815 cites W2091403060 @default.
- W2030059815 cites W2093081950 @default.
- W2030059815 cites W2096145898 @default.
- W2030059815 cites W2100415063 @default.
- W2030059815 cites W2110866266 @default.
- W2030059815 cites W2114583368 @default.
- W2030059815 cites W2128582518 @default.
- W2030059815 cites W2133970626 @default.
- W2030059815 cites W2134241003 @default.
- W2030059815 cites W2139222206 @default.
- W2030059815 cites W2151173133 @default.
- W2030059815 cites W2154706535 @default.
- W2030059815 cites W2159042889 @default.
- W2030059815 cites W2160387316 @default.
- W2030059815 cites W2161412670 @default.
- W2030059815 cites W2161745286 @default.
- W2030059815 cites W2167528320 @default.
- W2030059815 cites W2181227211 @default.